Publications by authors named "S M Dhanasekaran"

This study explores the thermal conductivity and viscosity of water-based nanofluids containing silicon dioxide, graphene oxide, titanium dioxide, and their hybrids across various concentrations (0 to 1 vol%) and temperatures (30 to 60 °C). The nanofluids, characterized using multiple methods, exhibited increased viscosity and thermal conductivity compared to water, with hybrid nanofluids showing superior performance. Graphene oxide nanofluids displayed the highest thermal conductivity and viscosity ratios, with increases of 52% and 177% at 60 °C and 30 °C, respectively, for a concentration of 1 vol% compared to base fluid.

View Article and Find Full Text PDF

Breast cancer (BC) is the most prevalent malignancy among women globally and the leading cause of cancer-related mortality. Consequently, there is an urgent need for new, effective treatment strategies for breast cancer. Research has shown that the enzyme nudix hydrolase 5 (NUDT5) plays a critical role in promoting breast cancer aggressiveness and serves as a key regulator of oncogenic pathways.

View Article and Find Full Text PDF

Acute adult supraglottitis is a serious and potentially life-threatening condition marked by inflammation of the supraglottic structures, posing a significant risk for rapid airway compromise. This case series highlights the varied presentations and management challenges associated with adult supraglottitis. The four cases involve adult males, most with uncontrolled diabetes mellitus, presenting with symptoms such as difficulty breathing, sore throat, dysphagia, and voice changes.

View Article and Find Full Text PDF

Background: Non-carious cervical lesions (NCCLs) present themselves as smooth saucer lesions with variable height and depth. Treatment of choice for these lesions should be aimed at conservative management by restoring the teeth. The present study aims to evaluate the micro-tensile bond strength in NCCLs after various surface pre-treatments.

View Article and Find Full Text PDF
Article Synopsis
  • * Approximately 90% of chiral compounds are sold as racemates, a mix of two enantiomers that can have different effects despite their identical structures.
  • * Recent advancements in asymmetric synthesis have increased interest in creating single enantiomers for drugs, and this review focuses on FDA-approved chiral medicines from 2022 and 2023, detailing their synthesis and enantiomeric properties.
View Article and Find Full Text PDF